199 related articles for article (PubMed ID: 25417705)
1. Cks1 is a critical regulator of hematopoietic stem cell quiescence and cycling, operating upstream of Cdk inhibitors.
Tomiatti V; Istvánffy R; Pietschmann E; Kratzat S; Hoellein A; Quintanilla-Fend L; von Bubnoff N; Peschel C; Oostendorp RA; Keller U
Oncogene; 2015 Aug; 34(33):4347-57. PubMed ID: 25417705
[TBL] [Abstract][Full Text] [Related]
2. Inhibitors of SCF-Skp2/Cks1 E3 ligase block estrogen-induced growth stimulation and degradation of nuclear p27kip1: therapeutic potential for endometrial cancer.
Pavlides SC; Huang KT; Reid DA; Wu L; Blank SV; Mittal K; Guo L; Rothenberg E; Rueda B; Cardozo T; Gold LI
Endocrinology; 2013 Nov; 154(11):4030-45. PubMed ID: 24035998
[TBL] [Abstract][Full Text] [Related]
3. Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase.
Bashir T; Dorrello NV; Amador V; Guardavaccaro D; Pagano M
Nature; 2004 Mar; 428(6979):190-3. PubMed ID: 15014502
[TBL] [Abstract][Full Text] [Related]
4. The SKP2 E3 ligase regulates basal homeostasis and stress-induced regeneration of HSCs.
Rodriguez S; Wang L; Mumaw C; Srour EF; Lo Celso C; Nakayama K; Carlesso N
Blood; 2011 Jun; 117(24):6509-19. PubMed ID: 21502543
[TBL] [Abstract][Full Text] [Related]
5. Vorinostat enhances protein stability of p27 and p21 through negative regulation of Skp2 and Cks1 in human breast cancer cells.
Uehara N; Yoshizawa K; Tsubura A
Oncol Rep; 2012 Jul; 28(1):105-10. PubMed ID: 22484732
[TBL] [Abstract][Full Text] [Related]
6. TGF-β activates APC through Cdh1 binding for Cks1 and Skp2 proteasomal destruction stabilizing p27kip1 for normal endometrial growth.
Pavlides SC; Lecanda J; Daubriac J; Pandya UM; Gama P; Blank S; Mittal K; Shukla P; Gold LI
Cell Cycle; 2016; 15(7):931-47. PubMed ID: 26963853
[TBL] [Abstract][Full Text] [Related]
7. Cks1 regulates cdk1 expression: a novel role during mitotic entry in breast cancer cells.
Westbrook L; Manuvakhova M; Kern FG; Estes NR; Ramanathan HN; Thottassery JV
Cancer Res; 2007 Dec; 67(23):11393-401. PubMed ID: 18056467
[TBL] [Abstract][Full Text] [Related]
8. Cryo-EM structure of SKP1-SKP2-CKS1 in complex with CDK2-cyclin A-p27KIP1.
Rowland RJ; Heath R; Maskell D; Thompson RF; Ranson NA; Blaza JN; Endicott JA; Noble MEM; Salamina M
Sci Rep; 2023 Jul; 13(1):10718. PubMed ID: 37400515
[TBL] [Abstract][Full Text] [Related]
9. Cks1 promotion of S phase entry and proliferation is independent of p27Kip1 suppression.
Hoellein A; Graf S; Bassermann F; Schoeffmann S; Platz U; Hölzlwimmer G; Kröger M; Peschel C; Oostendorp R; Quintanilla-Fend L; Keller U
Mol Cell Biol; 2012 Jul; 32(13):2416-27. PubMed ID: 22508990
[TBL] [Abstract][Full Text] [Related]
10. p27T187A knockin identifies Skp2/Cks1 pocket inhibitors for advanced prostate cancer.
Zhao H; Lu Z; Bauzon F; Fu H; Cui J; Locker J; Zhu L
Oncogene; 2017 Jan; 36(1):60-70. PubMed ID: 27181203
[TBL] [Abstract][Full Text] [Related]
11. Cks1 proteasomal degradation is induced by inhibiting Hsp90-mediated chaperoning in cancer cells.
Khattar V; Fried J; Xu B; Thottassery JV
Cancer Chemother Pharmacol; 2015 Feb; 75(2):411-20. PubMed ID: 25544127
[TBL] [Abstract][Full Text] [Related]
12. Oncostatin M induces growth arrest by inhibition of Skp2, Cks1, and cyclin A expression and induced p21 expression.
Halfter H; Friedrich M; Resch A; Kullmann M; Stögbauer F; Ringelstein EB; Hengst L
Cancer Res; 2006 Jul; 66(13):6530-9. PubMed ID: 16818624
[TBL] [Abstract][Full Text] [Related]
13. SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis.
Calvisi DF; Ladu S; Pinna F; Frau M; Tomasi ML; Sini M; Simile MM; Bonelli P; Muroni MR; Seddaiu MA; Lim DS; Feo F; Pascale RM
Gastroenterology; 2009 Nov; 137(5):1816-26.e1-10. PubMed ID: 19686743
[TBL] [Abstract][Full Text] [Related]
14. Structural basis of the Cks1-dependent recognition of p27(Kip1) by the SCF(Skp2) ubiquitin ligase.
Hao B; Zheng N; Schulman BA; Wu G; Miller JJ; Pagano M; Pavletich NP
Mol Cell; 2005 Oct; 20(1):9-19. PubMed ID: 16209941
[TBL] [Abstract][Full Text] [Related]
15. HOXA10 expression induced by Abl kinase inhibitors enhanced apoptosis through PI3K pathway in CML cells.
Sugimoto Y; Nakamura S; Okinaka K; Hirano I; Ono T; Shigeno K; Shinjo K; Ohnishi K
Leuk Res; 2008 Jun; 32(6):962-71. PubMed ID: 18190961
[TBL] [Abstract][Full Text] [Related]
16. Three different binding sites of Cks1 are required for p27-ubiquitin ligation.
Sitry D; Seeliger MA; Ko TK; Ganoth D; Breward SE; Itzhaki LS; Pagano M; Hershko A
J Biol Chem; 2002 Nov; 277(44):42233-40. PubMed ID: 12140288
[TBL] [Abstract][Full Text] [Related]
17. Specific small molecule inhibitors of Skp2-mediated p27 degradation.
Wu L; Grigoryan AV; Li Y; Hao B; Pagano M; Cardozo TJ
Chem Biol; 2012 Dec; 19(12):1515-24. PubMed ID: 23261596
[TBL] [Abstract][Full Text] [Related]
18. Activation of ubiquitin ligase SCF(Skp2) by Cks1: insights from hydrogen exchange mass spectrometry.
Yao ZP; Zhou M; Kelly SE; Seeliger MA; Robinson CV; Itzhaki LS
J Mol Biol; 2006 Oct; 363(3):673-86. PubMed ID: 16979657
[TBL] [Abstract][Full Text] [Related]
19. High-throughput screening AlphaScreen assay for identification of small-molecule inhibitors of ubiquitin E3 ligase SCFSkp2-Cks1.
Ungermannova D; Lee J; Zhang G; Dallmann HG; McHenry CS; Liu X
J Biomol Screen; 2013 Sep; 18(8):910-20. PubMed ID: 23589337
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of Cks1 and Skp2 with TNFα/NF-κB signaling in chronic progressive nephropathy.
Suzuki S; Fukasawa H; Misaki T; Togawa A; Ohashi N; Kitagawa K; Kotake Y; Niida H; Hishida A; Yamamoto T; Kitagawa M
Genes Cells; 2011 Nov; 16(11):1110-20. PubMed ID: 22017545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
